Not by systems alone: replicability assessment of disease expression signals
暂无分享,去创建一个
G. Lyon | J. Gillis | Sara Ballouz | M. Tzetis | L. Faivre | M. Crow | Jonathan Crain | C. Keegan | S. Kitsiou-Tzeli | Max J. Dörfel | S. Kitsiou‐Tzeli
[1] Benjamin J. Strober,et al. Identification of rare-disease genes in diverse undiagnosed cases using whole blood transcriptome sequencing and large control cohorts , 2018, bioRxiv.
[2] L. Tora,et al. Homozygous TAF8 mutation in a patient with intellectual disability results in undetectable TAF8 protein, but preserved RNA polymerase II transcription , 2018, Human molecular genetics.
[3] Esti Yeger-Lotem,et al. RSRC1 mutation affects intellect and behaviour through aberrant splicing and transcription, downregulating IGFBP3 , 2018, Brain : a journal of neurology.
[4] Helena Kuivaniemi,et al. A review of genome‐wide transcriptomics studies in Parkinson's disease , 2018, The European journal of neuroscience.
[5] Jaques Reifman,et al. A strategy for evaluating pathway analysis methods , 2017, BMC Bioinformatics.
[6] Funded Statistical Methods groups-AWG,et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing , 2017 .
[7] Eugene I. Drigalenko,et al. Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis , 2017, Translational Psychiatry.
[8] Thomas Meitinger,et al. Genetic diagnosis of Mendelian disorders via RNA sequencing , 2017, Nature Communications.
[9] Paul D Thomas,et al. The Gene Ontology and the Meaning of Biological Function. , 2017, Methods in molecular biology.
[10] Tin Chi Nguyen,et al. TOMAS: A novel TOpology-aware Meta-Analysis approach applied to System biology , 2016, BCB.
[11] Benjamin Haibe-Kains,et al. Study of Meta-analysis strategies for network inference using information-theoretic approaches , 2016, 2016 27th International Workshop on Database and Expert Systems Applications (DEXA).
[12] K. Ihara,et al. De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia , 2016, Journal of Human Genetics.
[13] N. Pervaiz,et al. The Parkinson Disease gene SNCA: Evolutionary and structural insights with pathological implication , 2016, Scientific Reports.
[14] E. Nogales,et al. Structure of promoter-bound TFIID and model of human pre-initiation complex assembly , 2016, Nature.
[15] M. Sobrido,et al. Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico , 2016, Journal of the Neurological Sciences.
[16] Jing Zhao,et al. A Burden of Rare Variants Associated with Extremes of Gene Expression in Human Peripheral Blood. , 2016, American journal of human genetics.
[17] Giulio Genovese,et al. Schizophrenia risk from complex variation of complement component 4 , 2016, Nature.
[18] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[19] Edward Yang,et al. TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations , 2015, American journal of human genetics.
[20] Sara Ballouz,et al. Guidance for RNA-seq co-expression network construction and analysis: safety in numbers , 2015, Bioinform..
[21] Daniel S. Himmelstein,et al. Understanding multicellular function and disease with human tissue-specific networks , 2015, Nature Genetics.
[22] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[23] Mohamed Abouelhoda,et al. Accelerating novel candidate gene discovery in neurogenetic disorders via whole-exome sequencing of prescreened multiplex consanguineous families. , 2015, Cell reports.
[24] Guoli Ji,et al. Aberrant Gene Expression in Humans , 2015, PLoS genetics.
[25] S. Teng,et al. RNA Sequencing in Schizophrenia , 2015, Bioinformatics and biology insights.
[26] M. Owen,et al. Genetics of schizophrenia , 2005, Current Opinion in Behavioral Sciences.
[27] G. Miller,et al. VMAT2 and Parkinson’s disease: harnessing the dopamine vesicle , 2014, Expert review of neurotherapeutics.
[28] Eric S. Lander,et al. A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.
[29] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[30] G. Tseng,et al. Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders , 2014, Genes, brain, and behavior.
[31] Dvir Dahary,et al. Microcephaly thin corpus callosum intellectual disability syndrome caused by mutated TAF2. , 2013, Pediatric neurology.
[32] L. Siever,et al. Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.
[33] Dong Wook Han,et al. A central role for TFIID in the pluripotent transcription circuitry , 2013, Nature.
[34] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[35] Xiang Wan,et al. Gemma: a resource for the reuse, sharing and meta-analysis of expression profiling data , 2012, Bioinform..
[36] William Stafford Noble,et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors , 2012, Genome research.
[37] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[38] K. Mayilyan. Complement genetics, deficiencies, and disease associations , 2012, Protein & Cell.
[39] Patrick R Hof,et al. Optimizing the phenotyping of rodent ASD models: enrichment analysis of mouse and human neurobiological phenotypes associated with high-risk autism genes identifies morphological, electrophysiological, neurological, and behavioral features , 2012, Molecular Autism.
[40] K. Hansen,et al. Sequencing technology does not eliminate biological variability , 2011, Nature Biotechnology.
[41] F. Müller,et al. Developmental regulation of transcription initiation: more than just changing the actors. , 2010, Current opinion in genetics & development.
[42] Pablo V Gejman,et al. The role of genetics in the etiology of schizophrenia. , 2010, The Psychiatric clinics of North America.
[43] I. Hanbauer,et al. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression , 2010, Proceedings of the National Academy of Sciences.
[44] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[45] R. Schliebs,et al. Synaptotagmins in Neurodegeneration , 2009, Anatomical record.
[46] P. Garred,et al. MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. , 2009, Molecular immunology.
[47] L. Liang,et al. Mapping complex disease traits with global gene expression , 2009, Nature Reviews Genetics.
[48] E. Dermitzakis. From gene expression to disease risk , 2008, Nature Genetics.
[49] Bin Zhang,et al. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..
[50] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[51] B. Migeon. Why females are mosaics, X-chromosome inactivation, and sex differences in disease. , 2007, Gender medicine.
[52] R. Jirtle,et al. Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.
[53] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[54] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[55] D. Goldstein,et al. UCHL‐1 is not a Parkinson's disease susceptibility gene , 2006, Annals of neurology.
[56] B. Harper. Huntington Disease , 2005, Journal of the Royal Society of Medicine.
[57] G. Bates. History of genetic disease: The molecular genetics of Huntington disease — a history , 2005, Nature Reviews Genetics.
[58] E. Kipreos,et al. Developmental cell biology: C. elegans cell cycles: invariance and stem cell divisions , 2005, Nature Reviews Molecular Cell Biology.
[59] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Raser,et al. Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.
[61] D. Goldstein,et al. UCHL1 is a Parkinson's disease susceptibility gene. , 2004 .
[62] D. Maraganore,et al. UCHL1 is a Parkinson's disease susceptibility gene , 2004, Annals of neurology.
[63] P. Bauer,et al. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington’s disease-like phenotype , 2004, Journal of Medical Genetics.
[64] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[65] H. Kitano. Systems Biology: A Brief Overview , 2002, Science.